TG02
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TG02, covering 2022-01-26 to 2025-11-26. Get the full timeline:
Most recent: Clinical Trial Update: Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma. [Phase 1]